Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
VANTAGEMED CORPListing unverified | BuyD (derivative) | $3.3K | ClusterFirst in 12mo | SEC | |
VANTAGEMED CORPListing unverified | Buy | $10K | conv 89ClusterFirst in 12mo | SEC | |
VANTAGEMED CORPListing unverified | BuyD (derivative) | $2.8K | ClusterFirst in 12mo | SEC | |
VANTAGEMED CORPListing unverified | AwardD (derivative) | $26.5K | SEC | ||
VANTAGEMED CORPListing unverified | AwardD (derivative) | $69K | SEC |